Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Amdipharm UK Limited, Capital House, 85 King William Street, London EC4N 7BL, UK
For the prophylaxis and treatment of infections caused by erythromycin-sensitive organisms.
Erythromycin is highly effective in the treatment of a great variety of clinical infections such as:
1. Upper Respiratory Tract infections: tonsillitis, peritonsillar abscess, pharyngitis, laryngitis, sinusitis, secondary infections in influenza and common colds
2. Lower Respiratory Tract infections: tracheitis, acute and chronic bronchitis, pneumonia (lobar pneumonia, bronchopneumonia, primary atypical pneumonia), bronchiectasis, Legionnaire’s disease
3. Ear infection: otitis media and otitis externa, mastoiditis
4. Oral infections: gingivitis, Vincent’s angina
5. Eye infections: blepharitis
6. Skin and soft tissue infections: boils and carbuncles, paronychia, abscesses, pustular acne, impetigo, cellulitis, erysipelas
7. Gastrointestinal infections: cholecystitis, staphylococcal enterocolitis
8. Prophylaxis: pre- and post- operative trauma, burns, rheumatic fever
9. Other infections: osteomyelitis, urethritis, gonorrhoea, syphilis, lymphogranuloma venereum, diphtheria, prostatitis, scarlet fever
Note: Erythromycin has also proved to be of value in endocarditis and septicaemia, but in these conditions initial administration of erythromycin lactobionate by the intravenous route is advisable.
2g/day in divided doses. For severe infections up to 4g/day in divided doses.
30 mg/kg/day in divided doses. For severe infections up to 50 mg/kg/day in divided doses.
Normal dose: 250mg four times a day or 500mg twice daily.
30mg/kg/day in divided doses. For severe infections up to 50mg/kg/day in divided doses.
Normal dose: 125mg four times a day or 250mg twice daily.
Presentations are available for adults and children over 8 years, children aged 2-8 years, and for children under 2 years.
For oral administrations.
Symptoms: hearing loss, severe nausea, vomiting and diarrhoea.
Management: gastric lavage, general supportive measures.
Bottles: 24 months. Once reconstituted Erythroped SF should be used within 7 days.
Sachets: 24 months.
None.
High density polyethylene bottles, 100ml or 140ml, with polypropylene cap which may be a child resistant cap.
Sachets; 44GSM Paper / 12 GSM LDPE / 9Ξm A1 foil / 34 GSM LDPE
No special requirements for disposal.
ÂĐ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.